Services
Market Access in Saudi Arabia
Get your product to the patients who need it in Saudi Arabia: early access, hospital formularies, key opinion leaders and the right distributors.
Solutions
Market Access: pick the part you need
Overview
From SFDA approval to patients receiving your product
An SFDA approval does not mean patients get your product. Doctors need to know it. Hospitals need to list it on their formulary. Payers need to see its value against the alternatives. Some patients need it before registration.
PharmaKnowl helps you plan and deliver access in Saudi Arabia, from early access programs to formulary listing and engagement with key opinion leaders.
What we offer
Market access services
- Early access: supply patients who need a medicine before it is registered, through the Named Patient Program or the Special Access Program. No local entity to import? Read about the Importer of Record.
- Hospital formulary listing: prepare the file that hospital pharmacy and therapeutics committees review.
- Value evidence: disease prevalence, patient numbers, and comparison with existing treatments.
- Patient finding for rare diseases: locate the centres and doctors who treat your patients.
- Distribution: find the right distributors for each product. Independent service: no commission from any distributor.
Pricing
Get the right price approved by the SFDA
The SFDA approves the price of your medicine as part of registration. That price follows you into hospital tenders, formulary decisions and your margins for years.
We prepare your pricing file, check it against the reference prices the SFDA will look at, and help you challenge a pricing decision when it falls short.
Why PharmaKnowl
Regulatory and access advice from one independent team
- Based in Riyadh, with former SFDA experts
- Independent: we do not sell or distribute products
- Your licences stay under your control
- All life science products
Frequently asked questions
What does market access mean in Saudi Arabia?
It is the work that gets an approved product to patients: pricing, hospital formulary listing, engagement with doctors, and in some cases early access before registration.
Can patients get a medicine before SFDA registration?
In some cases, yes, through a named patient program or a special access program. We can tell you which route fits your product.
Is PharmaKnowl a distributor?
No. We are an independent consultancy and receive no commission from any distributor. We help you choose distributors, but we do not distribute, sell or import products.

Who you will work with
The PharmaKnowl Team
Regulatory, pharmacovigilance and quality experts, fully based in our Riyadh office. A senior consultant follows your project from the first call to delivery.
- 12+Years of experience
- 2.7kDelivered projects
- 480+Global clients
Trusted by global pharma and rare-disease leaders







Contact our team
Request a proposal: Market Access
Schedule a call or ask for a proposal for your product.
- A senior consultant reviews your request.
- Your enquiry goes to our team in Riyadh.
- Prefer to talk?


